SBIR-STTR Award

Yield Enhancement Through Gene Discovery for Disease Control
Award last edited on: 4/4/02

Sponsored Program
SBIR
Awarding Agency
DOE
Total Award Amount
$824,999
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Scott Uknes

Company Information

Icoria Inc (AKA: Paradigm Genetics Inc )

108 Alexander Drive
Research Triangle Park, NC 27709
   (919) 425-3000
   info@paragen.com
   N/A
Location: Single
Congr. District: 04
County: Durham

Phase I

Contract Number: DE-FG02-98ER82633
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1998
Phase I Amount
$75,000
Diseases of major crop plants significantly reduce yield and increase the amount of fuel and chemical resources expended by farmers. The development of disease resistant transgenic plants and safer, more effective fungicides could help address this problem. This project will utilize cloning, sequencing, and gene expression profiling of novel genes involved in disease and resistance. In Phase I, gene sets will be isolated from one important cropspecies and one filamentous fungal pathogen for use in gene expression profiling arrays. These arrays will be used to identify novel plant and fungal genes induced in plant resistance and disease interactions.

Commercial Applications and Other Benefits as described by the awardee:
The development of disease tolerant monocot crops and safer, more effective fungicides could generate revenues of more than $20 million/year from the seeds and chemical industries.

Phase II

Contract Number: DE-FG02-98ER82633
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
1999
Phase II Amount
$749,999
Diseases of major crop plants significantly reduce yield and increase the amount of fuel and chemical resources expended by farmers. An increase of only 1 percent in crop yield will lead to approximately $64 million in on-farm fuel savings. In this project, the identification, cloning, sequencing, and gene-expression profiling of novel genes involved in disease and resistance will be utilized to generate higher-yield, disease-tolerant crops and crop-protection active ingredients that are safer, more effective, and that work via novel modes of action. In Phase I, gene sets were identified from the rice blast fungus (M. grisea) and from rice responding to pathogens. These gene sets were used for gene-expression profiling that allowed the identification of more than 50 rice genes and more than 100 rice blast genes related to disease and resistance. In Phase II, the genes discovered in Phase I, along with additional genes discovered in Phase II, will be evaluated as potential tools to enhance plant resistance, as potential tools for plant activator screening, and as potential fungicide targets. This will be accomplished using novel library construction techniques, novel gene-expression profiling and analysis tools, and gene-expression profiling of known fungicides and resistance inducers. Commercial Application and other Benefits as described by the awardee: The technology should be suitable for licensing to agricultural companies for the development of disease-tolerant crops and safer, more effective, novel mode-of-action fungicides. In addition, yield enhancement of maize, wheat, and other monocots should significantly reduce the petroleum used per bushel of grain harvested. Furthermore, human and animal health will benefit from reduced fungal myco-toxins in food and grain.